Company profile
- Industry
- Pharmaceuticals
- Founded
- 1892
- Headquarters
- Stamford, United States
- Ownership
- In Chapter 11 bankruptcy proceedings
Profiles are auto-generated and infrequently updated.
Decisions on record
2 verified Decision Records on Purdue Pharma, and the casebook each one belongs to.
| Fork date | Decision type | What Purdue Pharma chose | Where it stood | The story | Casebook |
|---|---|---|---|---|---|
| 2007 | The Pricing Lens | Keep selling machine running | criminal fine of $3.544 billion plus $2 billion in criminal forfeiture, the largest penalties ever levied against a pharmaceutical manufacturer (2026-04) | Read the story → | The Pricing Lens Casebook → |
| 2019 | The Fall | Bankruptcy shield for family | Purdue Pharma dissolved and operations transferred to Knoa Pharma LLC, barred from marketing opioids (2026-05) | Read the story → | The Fall Casebook → |
Videos on Purdue Pharma
Run one of these yourself
The decisions Purdue Pharma faced, as kits you can run.
Each pack takes one of these decisions and gives you the framework, a deck for the room, a model that resolves to one number, and the sourced cases behind it. $499, one-time.
The analyses
The Engineered Outcome · Business Model
Purdue Pleaded Guilty Again in 2020: The Misconduct Ran From 2007 to at Least 2017
The story is that Purdue was caught in 2007 and stopped. It wasn't. Purdue LP pleaded guilty again in 2020 for misconduct running from May 2007 through at least March 2017—and the engine was a five-sentence letter, a label phrase, and a sales force it called its most valuable resource.
8 min
The Fall · Crisis & Reinvention
Purdue's 2007 Reckoning Ended in Misdemeanors — the $11 Billion Escape Hatch Held Until 2024
OxyContin killed across two decades while the people who profited stayed untouched. The 2007 'reckoning' fined a subsidiary and gave executives misdemeanors. It took until a 5-4 Supreme Court ruling in 2024 to close the escape hatch on $11 billion.
8 min
The Fall · Crisis & Reinvention
After a Six-Year Legal Maze, a 5–4 Ruling Raised the Sacklers' Purdue Deal to $7.4 Billion
The popular story says the Sacklers were brought to justice. The real one: a six-year legal maze that nearly bought the family permanent immunity for $4.3 billion, until a 5–4 Supreme Court ruling forced a third deal worth $7.4 billion.
8 min